Emergent Autoimmunity in Graft-versus-host Disease

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2005 Mar 5

PMID 15746077

Citations 51

Authors

Elizabeth Tivol

Richard Komorowski

William R Drobyski

Affiliations

Soon will be listed here.

Abstract

Donor T-cell recognition of host alloantigens presented by host antigen-presenting cells (APCs) is necessary for the induction of graft-versus-host disease (GVHD), but whether direct alloreactivity is sufficient for the propagation of GVHD is unknown. In this study, we demonstrate that GVHD cannot be effectively propagated through the direct pathway of allorecognition. Rather, donor T-cell recognition of antigens through the indirect pathway is necessary for the perpetuation of GVHD. Furthermore, GVHD results in the breaking of self tolerance, resulting in the emergence of donor T cells that can cause autoimmune disease in syngeneic recipients. Notably, GVHD-induced autoreactivity is donor APC dependent, transferable into secondary hosts, and involves cells of the innate immune system. These results indicate that donor T-cell--mediated pathologic damage during GVHD becomes donor APC dependent and provide a mechanistic explanation for the long-standing observation that GVHD is associated with autoimmune clinical manifestations.

Citing Articles

Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.

Bracken S, Suthers A, DiCioccio R, Su H, Anand S, Poe J Blood Adv. 2023; 8(3):667-680.

PMID: 38113462 PMC: 10839617. DOI: 10.1182/bloodadvances.2023010362.

Harnessing and honing mesenchymal stem/stromal cells for the amelioration of graft-versus-host disease.

Jaing T, Chang T, Chiu C World J Stem Cells. 2023; 15(4):221-234.

PMID: 37180998 PMC: 10173808. DOI: 10.4252/wjsc.v15.i4.221.

Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.

Poe J, Fang J, Zhang D, Lee M, DiCioccio R, Su H JCI Insight. 2023; 8(11).

PMID: 37129971 PMC: 10393230. DOI: 10.1172/jci.insight.169732.

Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations.

Baumrin E, Loren A, Falk S, Mays J, Cowen E J Am Acad Dermatol. 2022; 90(1):1-16.

PMID: 36572065 PMC: 10287844. DOI: 10.1016/j.jaad.2022.12.024.

Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.

Cuvelier G, Schoettler M, Buxbaum N, Pinal-Fernandez I, Schmalzing M, Distler J Transplant Cell Ther. 2022; 28(8):426-445.

PMID: 35662591 PMC: 9557927. DOI: 10.1016/j.jtct.2022.05.038.

References

Morrissey P, Charrier K, Braddy S, Liggitt D, Watson J . CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med. 1993; 178(1):237-44. PMC: 2191069. DOI: 10.1084/jem.178.1.237. View

Benichou G, Takizawa P, Olson C, McMillan M, Sercarz E . Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med. 1992; 175(1):305-8. PMC: 2119070. DOI: 10.1084/jem.175.1.305. View

Sadlack B, Merz H, Schorle H, Schimpl A, Feller A, Horak I . Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 1993; 75(2):253-61. DOI: 10.1016/0092-8674(93)80067-o. View

Parkman R . Is chronic graft versus host disease an autoimmune disease?. Curr Opin Immunol. 1993; 5(5):800-3. DOI: 10.1016/0952-7915(93)90140-n. View

Powrie F, Leach M, Mauze S, Caddle L, Coffman R . Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol. 1993; 5(11):1461-71. DOI: 10.1093/intimm/5.11.1461. View

Powrie F, Correa-Oliveira R, Mauze S, Coffman R . Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med. 1994; 179(2):589-600. PMC: 2191378. DOI: 10.1084/jem.179.2.589. View

Hollander G, Widmer B, Burakoff S . Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease. J Immunol. 1994; 152(4):1609-17. View

Emlen W, Niebur J, Kadera R . Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol. 1994; 152(7):3685-92. View

Yamamoto M, Sugihara K, Ohtsuki F, Tsujino Y, Tanaka A, Kamiya T . Generation of self HLA-DR-specific CD3+CD4-CD8+ cytotoxic T cells in chronic graft-versus-host disease. Bone Marrow Transplant. 1994; 14(4):525-33. View

10.

Suzuki H, Kundig T, Furlonger C, Wakeham A, Timms E, Matsuyama T . Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science. 1995; 268(5216):1472-6. DOI: 10.1126/science.7770771. View

11.

Albert M, Sauter B, Bhardwaj N . Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 1998; 392(6671):86-9. DOI: 10.1038/32183. View

12.

Bellone M, Iezzi G, Rovere P, Galati G, Ronchetti A, Protti M . Processing of engulfed apoptotic bodies yields T cell epitopes. J Immunol. 1998; 159(11):5391-9. View

13.

van den Brink M, Moore E, Ferrara J, Burakoff S . Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity. Transplantation. 2000; 69(3):446-9. DOI: 10.1097/00007890-200002150-00026. View

14.

Lin M, Tseng L, Frangoul H, Gooley T, Pei J, Barsoukov A . Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation. Blood. 2000; 95(12):3832-9. View

15.

Auffermann-Gretzinger S, Lossos I, Vayntrub T, Leong W, Grumet F, Blume K . Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. Blood. 2002; 99(4):1442-8. DOI: 10.1182/blood.v99.4.1442. View

16.

Strober W, Fuss I, Blumberg R . The immunology of mucosal models of inflammation. Annu Rev Immunol. 2002; 20:495-549. DOI: 10.1146/annurev.immunol.20.100301.064816. View

17.

Drobyski W, Komorowski R, Logan B, Gendelman M . Role of the passive apoptotic pathway in graft-versus-host disease. J Immunol. 2002; 169(3):1626-33. DOI: 10.4049/jimmunol.169.3.1626. View

18.

Zhang Y, Shlomchik W, Joe G, Louboutin J, Zhu J, Rivera A . APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease. J Immunol. 2002; 169(12):7111-8. DOI: 10.4049/jimmunol.169.12.7111. View

19.

Clark F, Freeman L, Dzionek A, Schmitz J, McMullan D, Simpson P . Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease. Transplantation. 2003; 75(2):221-5. DOI: 10.1097/01.TP.0000041783.34083.11. View

20.

Teshima T, Reddy P, Liu C, Williams D, Cooke K, Ferrara J . Impaired thymic negative selection causes autoimmune graft-versus-host disease. Blood. 2003; 102(2):429-35. DOI: 10.1182/blood-2003-01-0266. View